Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for igg kappa multiple myeloma
Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for igg kappa multiple myeloma"
- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT A 41-year-old male with IgG kappa multiple myeloma is described. He developed a free gamma heavy chain without an accompanying light chain following high-dose chemotherapy and
autologous peripheral blood stem cell transplantation. The free gamma heavy chain was detected in serum and urine specimens 2 months after transplant, and eventually evolved into an IgG
kappa monoclonal protein with electrophoretic properties similar to the original myeloma protein. Although the origin of the free gamma heavy chain remains uncertain, it was most likely
related to the underlying plasma cell malignancy and, therefore, was an early sign of disease relapse. _Bone Marrow Transplantation_ (2001) 27, 663–666. Access through your institution Buy
or subscribe This is a preview of subscription content, access via your institution ACCESS OPTIONS Access through your institution Subscribe to this journal Receive 12 print issues and
online access $259.00 per year only $21.58 per issue Learn more Buy this article * Purchase on SpringerLink * Instant access to full article PDF Buy now Prices may be subject to local taxes
which are calculated during checkout ADDITIONAL ACCESS OPTIONS: * Log in * Learn about institutional subscriptions * Read our FAQs * Contact customer support SIMILAR CONTENT BEING VIEWED BY
OTHERS THE SIGNIFICANCE OF FREE LIGHT-CHAIN RATIO IN LIGHT-CHAIN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE: A FLOW CYTOMETRY SUB-STUDY OF THE ISTOPMM SCREENING STUDY Article Open
access 18 December 2024 IMMUNOPHENOTYPIC ASSESSMENT OF CLONAL PLASMA CELLS AND B-CELLS IN BONE MARROW AND BLOOD IN THE DIAGNOSTIC CLASSIFICATION OF EARLY STAGE MONOCLONAL GAMMOPATHIES: AN
ISTOPMM STUDY Article Open access 11 December 2023 MULTIPLE MYELOMA Article 27 June 2024 REFERENCES * Landis SH, Murray T, Bolden S _et al_. Cancer statistics 1999 _CA Cancer J Clin_ 1999
49: 8–31 Article CAS Google Scholar * Boccadoro M, Peleri A . Diagnosis, prognosis, and standard treatment of multiple myeloma _Hematol Oncol Clin North Am_ 1997 11: 111–131 Article CAS
Google Scholar * Barlogie B, Jagannath S, Desikan KR _et al_. Total therapy with tandem transplants for newly diagnosed multiple myeloma _Blood_ 1999 93: 55–65 CAS Google Scholar * Zent
CS, Wilson CS, Tricot G _et al_. Oligoclonal protein bands and Ig isotype switching in multiple myeloma treated with high-dose therapy and hematopoietic cell transplantation _Blood_ 1998
91: 3518–3523 CAS Google Scholar * Hovenga S, de Wolf JThM, Guikema JEJ _et al_. Autologous stem cell transplantation in multiple myeloma after VAD and EDAP courses: a high incidence of
oligoclonal serum Igs post transplantation _Bone Marrow Transplant_ 2000 25: 723–728. Article CAS Google Scholar * Guikema JEJ, Vellenga E, Veeneman JM _et al_. Multiple myeloma related
cells in patients undergoing autologous peripheral blood stem cell transplantation _Br J Haematol_ 1999 104: 748–754 Article CAS Google Scholar * Preud'Homme JL, Hurez D, Danon F _et
al_. Intracytoplasmic and surface-bound immunoglobulins in ‘nonsecretory’ and Bence–Jones myeloma _Clin Exp Immunol_ 1976 25: 428–436 CAS PubMed PubMed Central Google Scholar *
Preud'Homme JL, Brouet JC, Seligmann M . Cellular immunoglobulins in human γ- and α-heavy chain diseases _Clin Exp Immunol_ 1979 37: 283–291 CAS PubMed PubMed Central Google Scholar
* Fermand JP, Brouet JC . Heavy-chain diseases _Hematol Oncol Clin North Am_ 1999 13: 1281–1294 Article CAS Google Scholar * Fermand JP, Brouet JC, Danon F _et al_. Gamma heavy chain
‘disease’: heterogeneity of the clinicopathologic features. Report of 16 cases and review of the literature _Medicine_ 1989 68: 321–335 Article CAS Google Scholar * Tricot G, Barlogie B,
Jagannath S _et al_. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosomes 13 or abnormalities involving 11q and not with other karyotype
abnormalities _Blood_ 1995 86: 4250–4256 CAS PubMed Google Scholar * Rajkumar SV, Greipp PR . Prognostic factors in multiple myeloma _Hematol Oncol Clin North Am_ 1999 13: 1295–1314
Article CAS Google Scholar Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS * Department of Pathology and Laboratory Medicine, UCLA Medical Center, Los Angeles, CA, USA AW
Butch * Myeloma and Transplantation Research Center, University of Arkansas for Medical Sciences, AK, USA AW Butch, A Badros, KR Desikan & NC Munshi * South Central Arkansas Veterans
Health Care System, Little Rock, AK, USA NC Munshi Authors * AW Butch View author publications You can also search for this author inPubMed Google Scholar * A Badros View author publications
You can also search for this author inPubMed Google Scholar * KR Desikan View author publications You can also search for this author inPubMed Google Scholar * NC Munshi View author
publications You can also search for this author inPubMed Google Scholar RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE Butch, A., Badros, A., Desikan,
K. _et al._ Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for IgG kappa multiple myeloma. _Bone Marrow Transplant_ 27, 663–666 (2001).
https://doi.org/10.1038/sj.bmt.1702850 Download citation * Received: 26 September 2000 * Accepted: 07 December 2000 * Published: 23 April 2001 * Issue Date: 01 March 2001 * DOI:
https://doi.org/10.1038/sj.bmt.1702850 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not
currently available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * multiple myeloma * relapse * autologous stem cell
transplantation * heavy chain protein
Trending News
The recruitment of cd8+ t cells through ybx1 stabilization abrogates tumor intrinsic oncogenic role of mir155hg in lung adenocarcinomaABSTRACT Previous studies revealed that MIR155HG possessed an oncogenic role in many types of tumors including lung aden...
“Applied Statistics” | NatureIN his review of my book “Statistical Methods in Electrical Engineering” (Nature, March 19, p. 484), Mr. F. Downton crit...
State department reopens investigation into clinton emailsThe State Department said Thursday it has reopened its internal review of Hillary Clinton's use of a private email ...
Biological significance of fluorine-18-α-methyltyrosine (FAMT) uptake on PET in patients with oesophageal cancer18F-FAMT as an amino-acid tracer for positron emission tomography (PET) is useful for detecting human neoplasms. 18F-FAM...
Chelsea boss Thomas Tuchel could drop five players vs Dinamo ZagrebChelsea boss Thomas Tuchel could be set to make several changes for his side’s trip to Croatia to face Dinamo Zagreb in ...
Latests News
Cost-cutting tips for planning a wedding in a time of new tariffsWeddings in the United States are often dependent on goods imported from countries hit with new tariffs. Vendors and eng...
Expression of a free gamma heavy chain in serum following autologous stem cell transplantation for igg kappa multiple myelomaABSTRACT A 41-year-old male with IgG kappa multiple myeloma is described. He developed a free gamma heavy chain without ...
Of course, nbc and ioc have a lot in commonThe high points, low points and ticklish talking points of the weekend that was: Yessss! NBC Sports is where it’s at the...
Is Chandrababu Naidu hinting that he is open to NDA without Modi-Shah at the helm?Chandrababu Naidu's political script after exiting the NDA is still on the drawing board. His utterances reveal that his...
Everything you need to know about ‘protein-folding problem’ – but were too afraid to askIn CASP13, DeepMind’s performance was remarkable with a significant margin over the next competitor. But CASP14 saw the ...